{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:34:58Z","timestamp":1783154098537,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00277-022-04991-9","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T07:03:00Z","timestamp":1664866980000},"page":"2627-2631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy"],"prefix":"10.1007","volume":"101","author":[{"given":"Allen","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min P.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Sarode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim F.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Afraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9703-5047","authenticated-orcid":false,"given":"Sean G.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"4991_CR1","doi-asserted-by":"publisher","unstructured":"Rodeghiero F, Castaman G, Dini E (1987) Epidemiological investigation of the prevalence of von Willebrand\u2019s disease.\u00a0Blood\u00a069(2):454\u2013459.\u00a0https:\/\/doi.org\/10.1182\/blood.V69.2.454.454","DOI":"10.1182\/blood.V69.2.454.454"},{"issue":"8","key":"4991_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0025-6196(12)61204-X","volume":"66","author":"ZM Ruggeri","year":"1991","unstructured":"Ruggeri ZM (1991) Structure and function of von Willebrand factor: relationship to von Willebrand\u2019s disease. Mayo Clin Proc 66(8):847\u2013861","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"4991_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajh.10298","volume":"72","author":"S Kumar","year":"2003","unstructured":"Kumar S, Pruthi RK, Nichols WL (2003) Acquired von Willebrand\u2019s syndrome: a single institution experience. Am J Hematol 72(4):243\u2013247","journal-title":"Am J Hematol"},{"issue":"14","key":"4991_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","volume":"132","author":"JP Fermand","year":"2018","unstructured":"Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G (2018) Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 132(14):1478\u20131485","journal-title":"Blood"},{"issue":"2","key":"4991_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/rth2.12481","volume":"5","author":"MY Abou-Ismail","year":"2021","unstructured":"Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY (2021) Acquired von Willebrand syndrome in monoclonal gammopathy\u2013A scoping review on hemostatic management. Res Pract Thromb Haemost 5(2):356\u2013365","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"4991_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/jth.13317","volume":"14","author":"M Lavin","year":"2016","unstructured":"Lavin M et al (2016) Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. J Thromb Haemost 14(6):1200\u20131205","journal-title":"J Thromb Haemost"},{"issue":"3","key":"4991_CR7","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/hae.13464","volume":"24","author":"W Thomas","year":"2018","unstructured":"Thomas W, Warner E, Cameron E, Symington E (2018) Successful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding: a case report. Haemophilia 24(3):e140\u2013e142","journal-title":"Haemophilia"},{"issue":"01","key":"4991_CR8","first-page":"01","volume":"41","author":"A Abendroth","year":"2021","unstructured":"Abendroth A, Fischer J, Hoffmann T, Scharf R, Bomke B (2021) Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance\u2013successful treatment with lenalidomide and dexamethasone. Hamostaseologie 41(01):01\u201301","journal-title":"Hamostaseologie"},{"key":"4991_CR9","doi-asserted-by":"publisher","unstructured":"Zoghi B, Shaughnessy P, Lyons RM, Helmer R, Bachier  C, LeMaistre\u00a0CF (2015) Treatment of acquired von Willebrand syndrome and prevention of bleeding postautologous stem cell transplant during severe pancytopenia with IVIG. Case Rep Hematol\u00a02015:3. https:\/\/doi.org\/10.1155\/2015\/809313","DOI":"10.1155\/2015\/809313"},{"key":"4991_CR10","doi-asserted-by":"publisher","unstructured":"Fricke WA, Brinkhous KM, Garris JB, Roberts\u00a0HR (1985) Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.\u00a0Blood\u00a066(3):562\u2013569.\u00a0https:\/\/doi.org\/10.1182\/blood.V66.3.562.562","DOI":"10.1182\/blood.V66.3.562.562"},{"issue":"2","key":"4991_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ajh.2830350210","volume":"35","author":"C Richard","year":"1990","unstructured":"Richard C et al (1990) Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 35(2):114\u2013117","journal-title":"Am J Hematol"},{"key":"4991_CR12","doi-asserted-by":"publisher","unstructured":"Budde U, Scharf RE, Franke P, Hartmann-budde K, Dent J, Ruggeri\u00a0ZM (1993) Elevated platelet count as a cause of abnormal von willebrand factor multimer distribution in plasma. Blood\u00a082(6):1749\u20131757.\u00a0https:\/\/doi.org\/10.1182\/blood.V82.6.1749.1749","DOI":"10.1182\/blood.V82.6.1749.1749"},{"key":"4991_CR13","doi-asserted-by":"publisher","unstructured":"Abou MY, Mbbch MYL, Rodgers  GM, Bray\u00a0PF (2021) \u201cAcquired von Willebrand syndrome in monoclonal gammopathy \u2013 \u00ad a scoping review on hemostatic management,\u201d. 356\u2013365. https:\/\/doi.org\/10.1002\/rth2.12481","DOI":"10.1002\/rth2.12481"},{"key":"4991_CR14","doi-asserted-by":"publisher","unstructured":"Franchini\u00a0M, Mannucci\u00a0PM (2020) \u201cAcquired von Willebrand syndrome: focused for hematologists,\u201d Haematologica. 105(8).\u00a0https:\/\/doi.org\/10.3324\/haematol.2020.255117","DOI":"10.3324\/haematol.2020.255117"},{"issue":"04","key":"4991_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1055\/s-0039-1696960","volume":"39","author":"S D\u00e9sage","year":"2019","unstructured":"D\u00e9sage S, Quellec SL, Karlin L, Lienhart A, Meunier S, Rugeri L (2019) A prolonged treatment response in acquired Von Willebrand syndrome. Hamostaseologie 39(04):409\u2013412. https:\/\/doi.org\/10.1055\/s-0039-1696960","journal-title":"Hamostaseologie"},{"key":"4991_CR16","doi-asserted-by":"publisher","unstructured":"Lavin M, Brophy TM, Rawley O, Sullivan JMO, Hayden PJ, Browne\u00a0PV (2016) \u201cLenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy,\u201d. 1200\u20131205.\u00a0https:\/\/doi.org\/10.1111\/jth.13317","DOI":"10.1111\/jth.13317"},{"issue":"10","key":"4991_CR17","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/sj.bjc.6600607","volume":"87","author":"K Dredge","year":"2002","unstructured":"Dredge K et al (2002) Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer 87(10):1166\u20131172","journal-title":"Br J Cancer"},{"issue":"2","key":"4991_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2141.2009.07730.x","volume":"146","author":"SJ Bowcock","year":"2009","unstructured":"Bowcock SJ, Patrick HE (2009) Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Br J Haematol 146(2):220\u2013222","journal-title":"Br J Haematol"},{"key":"4991_CR19","doi-asserted-by":"publisher","unstructured":"To\u00a0 L, Editor\u00a0THE (2018) \u201cSuccessful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding\u202f: a case report,\u201d no. February. 140\u2013142.\u00a0https:\/\/doi.org\/10.1111\/hae.13464","DOI":"10.1111\/hae.13464"},{"issue":"2","key":"4991_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.leu.2405062","volume":"22","author":"A Palumbo","year":"2008","unstructured":"Palumbo A et al (2008) Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma. Leukemia 22(2):414\u2013423","journal-title":"Leukemia"},{"issue":"11\u201312","key":"4991_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00508-022-02012-3","volume":"134","author":"G Jeryczynski","year":"2022","unstructured":"Jeryczynski G, Agis H, Eichinger-Hasenauer S, Krauth MT (2022) Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy. Wien Klin Wochenschr 134(11\u201312):478\u2013482. https:\/\/doi.org\/10.1007\/s00508-022-02012-3","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"4991_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/ccr3.2770","volume":"8","author":"C Nicol","year":"2020","unstructured":"Nicol C, Raj L, Guillerm G, Couturaud F, Eveillard J, Pan-Petesch B (2020) Acquired von Willebrand syndrome and lymphoproliferative disorders: a case report. Clin Case Rep 8(5):900\u2013904. https:\/\/doi.org\/10.1002\/ccr3.2770","journal-title":"Clin Case Rep"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04991-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:58:40Z","timestamp":1744207120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04991-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4991"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04991-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"22 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the individual described in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}